Related Experiment Videos
Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic
Peter Dubsky1, Christoph Tausch2
1Breast Centre, Hirslanden, Klinik St. Anna, Luzern, Switzerland; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austria.
European Journal of Cancer (Oxford, England : 1990)
|January 4, 2021
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients.
Breast cancer (Tokyo, Japan)·2026
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34.
Breast (Edinburgh, Scotland)·2025
What does addressing cancer inequalities really mean? Five principles that can drive global action.
European journal of cancer (Oxford, England : 1990)·2026
Acute and long-term outcomes of CD20-targeting CAR T-cell therapy in relapsed or refractory B-NHL: MB-CART20.1 Lymphoma phase I trial.
European journal of cancer (Oxford, England : 1990)·2026
Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women.
European journal of cancer (Oxford, England : 1990)·2026
Systemic inflammation and patient-reported quality of life as combined prognosticators in patients with solid tumors.
European journal of cancer (Oxford, England : 1990)·2026
Analysis of quality-adjusted time without symptoms or toxicity (Q-TWiST) in patients with metastatic hormone-sensitive prostate cancer from the ARASENS trial.
European journal of cancer (Oxford, England : 1990)·2026
Lazertinib plus pemetrexed and carboplatin in patients with EGFR-mutant advanced non-small cell lung cancer after progression on lazertinib.
European journal of cancer (Oxford, England : 1990)·2026
Liver-resident cellular determinants of oncolytic virotherapy in hepatocellular carcinoma: viral susceptibility and spatial immune remodeling.
Frontiers in cell and developmental biology·2026
Chemokines as regulators of CAR-T cell trafficking, function, and context-dependent tumor cell death.
Frontiers in immunology·2026
Efficacy of the Peritoneovenous Shunt as Palliative Care for Patients with Advanced Cancer with Refractory Ascites: A Randomized Controlled Trial (JIVROSG-0803 Study).
Interventional radiology (Higashimatsuyama-shi (Japan)·2026